Patient-Proxy and Societal Perspectives of Quality-of-Life Utilities in Children With Cleft Lip and Palate Managed With Surgical Repair vs No Repair in Ethiopia.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
entrez:
14
7
2022
pubmed:
15
7
2022
medline:
19
7
2022
Statut:
epublish
Résumé
In Ethiopia, more than 70% of infants with cleft lip and/or palate (CL/P) lack access to surgery. Infants who are untreated can experience severe malnutrition and extreme social stigma resulting in abandonment. Utilities are standardized measures of health-related quality of life (HRQOL) that inform health care resource allocation. However, CL/P utilities are missing from low- and middle-income countries (LMICs). To elicit utilities for untreated and surgically treated children with CL/P with consideration for social determinants of health from patient-proxy and societal participants. This cross-sectional study used patient proxies and societal participants in Addis Ababa, Ethiopia, from July 1, 2019, to January 30, 2020. Eligible patient proxies were caregivers of children younger than 18 years with nonsyndromic CL/P who were untreated or received surgery. Proxies were necessary as most patients were 0 to 4 years old and cannot reliably self-report. Eligible societal participants were 18 years and older with no family history of CL/P. Surgical treatment and social determinants of health. Participants measured utilities using the visual analog scale (VAS), time trade-off (TTO), and standard gamble (SG). In this study, 312 patient proxies and 135 societal participants were recruited. Mean (SD) utilities for untreated CL/P ranged from 0.57 (0.23) to 0.70 (0.22) from patient proxies and from 0.35 (0.21) to 0.8 (0.23) from societal participants, depending on utility instrument and cleft type. Surgical treatment was associated with a better HRQOL from the patient-proxy perspective (VAS, 0.17; 95% CI, 0.09 to 0.26; TTO, 0.15; 95% CI, 0.05 to 0.25) from the societal perspective (VAS, 0.21; 95% CI, 0.16 to 0.26; TTO, 0.17; 95% CI, 0.13 to 0.22; SG, 0.11; 95% CI, 0.06 to 0.15). Social determinants of health that were associated with patient-proxy utilities were income above the national mean (VAS, 0.10; 95% CI, 0.02 to 0.17; TTO, 0.11; 95% CI, 0.02 to 0.20), and religion (Christian vs other: TTO, -0.10; 95% CI, -0.17 to -0.03). From the societal perspective, the association between treatment and utilities was smaller in females compared with males (TTO, -0.05; 95% CI, -0.10 to -0.01). The findings of this study suggest that CL/P disease severity and surgical impact in Ethiopia were undervalued by previous estimates from high-income countries and were associated with social determinants of health. Utility studies from participants from LMICs are feasible and necessary for representing HRQOL in LMICs and addressing health inequalities.
Identifiants
pubmed: 35834253
pii: 2794211
doi: 10.1001/jamanetworkopen.2022.20900
pmc: PMC9284333
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2220900Subventions
Organisme : CIHR
Pays : Canada
Références
Value Health. 2018 Feb;21(2):124-130
pubmed: 29477389
Plast Reconstr Surg. 2012 Aug;130(2):408-414
pubmed: 22842412
Value Health. 2016 Sep - Oct;19(6):704-719
pubmed: 27712695
Gates Open Res. 2019 Sep 20;3:1543
pubmed: 31633086
Health Qual Life Outcomes. 2020 Mar 16;18(1):72
pubmed: 32178681
Qual Life Res. 1999 Sep;8(6):471-80
pubmed: 10548862
AIDS. 2008 Jul;22 Suppl 1:S123-30
pubmed: 18664944
Qual Life Res. 2016 Dec;25(12):2997-3008
pubmed: 27444779
Value Health. 2013 Sep-Oct;16(6):1091-9
pubmed: 24041360
Am J Trop Med Hyg. 2015 Jan;92(1):163-71
pubmed: 25371189
Health Econ. 2016 Feb;25 Suppl 1:140-61
pubmed: 26804361
Lancet Glob Health. 2014 Jun;2(6):e334-45
pubmed: 25103302
Plast Reconstr Surg Glob Open. 2019 Oct 28;7(10):e2487
pubmed: 31772907
Ethiop Med J. 2011 Jan;49(1):1-5
pubmed: 21456466
Health Qual Life Outcomes. 2019 Nov 5;17(1):165
pubmed: 31690327
J Craniofac Surg. 2017 Mar;28(2):334-337
pubmed: 27984437
Circ Cardiovasc Qual Outcomes. 2019 Sep;12(9):e005606
pubmed: 31514521
Bull World Health Organ. 2014 Mar 1;92(3):226-8
pubmed: 24700983
Surgery. 2015 May;157(5):834-5
pubmed: 25934019
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
BMC Med Res Methodol. 2017 Dec 6;17(1):162
pubmed: 29207961
J Plast Reconstr Aesthet Surg. 2014 Sep;67(9):1194-200
pubmed: 24888227
Cleft Palate Craniofac J. 2018 Jan 1;:1055665618760619
pubmed: 29561719
Arthritis Rheum. 2004 Oct 15;51(5):763-73
pubmed: 15478144
Value Health Reg Issues. 2018 Sep;16:61-65
pubmed: 30195092
Value Health. 2009 Mar-Apr;12(2):377-84
pubmed: 20667064
Value Health Reg Issues. 2020 Sep;22:7-14
pubmed: 31683254